418 related articles for article (PubMed ID: 22223806)
1. Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE.
Inamori K; Yoshida-Moriguchi T; Hara Y; Anderson ME; Yu L; Campbell KP
Science; 2012 Jan; 335(6064):93-6. PubMed ID: 22223806
[TBL] [Abstract][Full Text] [Related]
2. Xylosyl- and glucuronyltransferase functions of LARGE in α-dystroglycan modification are conserved in LARGE2.
Inamori K; Hara Y; Willer T; Anderson ME; Zhu Z; Yoshida-Moriguchi T; Campbell KP
Glycobiology; 2013 Mar; 23(3):295-302. PubMed ID: 23125099
[TBL] [Abstract][Full Text] [Related]
3. Mouse large can modify complex N- and mucin O-glycans on alpha-dystroglycan to induce laminin binding.
Patnaik SK; Stanley P
J Biol Chem; 2005 May; 280(21):20851-9. PubMed ID: 15788414
[TBL] [Abstract][Full Text] [Related]
4. Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissues.
Inamori K; Willer T; Hara Y; Venzke D; Anderson ME; Clarke NF; Guicheney P; Bönnemann CG; Moore SA; Campbell KP
J Biol Chem; 2014 Oct; 289(41):28138-48. PubMed ID: 25138275
[TBL] [Abstract][Full Text] [Related]
5. Exogenous expression of the glycosyltransferase LARGE1 restores α-dystroglycan matriglycan and laminin binding in rhabdomyosarcoma.
Beltrán D; Anderson ME; Bharathy N; Settelmeyer TP; Svalina MN; Bajwa Z; Shern JF; Gultekin SH; Cuellar MA; Yonekawa T; Keller C; Campbell KP
Skelet Muscle; 2019 May; 9(1):11. PubMed ID: 31054580
[TBL] [Abstract][Full Text] [Related]
6. Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection.
Hara Y; Kanagawa M; Kunz S; Yoshida-Moriguchi T; Satz JS; Kobayashi YM; Zhu Z; Burden SJ; Oldstone MB; Campbell KP
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17426-31. PubMed ID: 21987822
[TBL] [Abstract][Full Text] [Related]
7. O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding.
Yoshida-Moriguchi T; Yu L; Stalnaker SH; Davis S; Kunz S; Madson M; Oldstone MB; Schachter H; Wells L; Campbell KP
Science; 2010 Jan; 327(5961):88-92. PubMed ID: 20044576
[TBL] [Abstract][Full Text] [Related]
8. LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy.
Goddeeris MM; Wu B; Venzke D; Yoshida-Moriguchi T; Saito F; Matsumura K; Moore SA; Campbell KP
Nature; 2013 Nov; 503(7474):136-40. PubMed ID: 24132234
[TBL] [Abstract][Full Text] [Related]
9. The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated α-dystroglycan functional glycosylation.
Willer T; Inamori K; Venzke D; Harvey C; Morgensen G; Hara Y; Beltrán Valero de Bernabé D; Yu L; Wright KM; Campbell KP
Elife; 2014 Oct; 3():. PubMed ID: 25279699
[TBL] [Abstract][Full Text] [Related]
10. B4GAT1 is the priming enzyme for the LARGE-dependent functional glycosylation of α-dystroglycan.
Praissman JL; Live DH; Wang S; Ramiah A; Chinoy ZS; Boons GJ; Moremen KW; Wells L
Elife; 2014 Oct; 3():. PubMed ID: 25279697
[TBL] [Abstract][Full Text] [Related]
11. N-terminal domain on dystroglycan enables LARGE1 to extend matriglycan on α-dystroglycan and prevents muscular dystrophy.
Okuma H; Hord JM; Chandel I; Venzke D; Anderson ME; Walimbe AS; Joseph S; Gastel Z; Hara Y; Saito F; Matsumura K; Campbell KP
Elife; 2023 Feb; 12():. PubMed ID: 36723429
[TBL] [Abstract][Full Text] [Related]
12. Large induces functional glycans in an O-mannosylation dependent manner and targets GlcNAc terminals on alpha-dystroglycan.
Hu Y; Li ZF; Wu X; Lu Q
PLoS One; 2011 Feb; 6(2):e16866. PubMed ID: 21347376
[TBL] [Abstract][Full Text] [Related]
13. AGO61-dependent GlcNAc modification primes the formation of functional glycans on α-dystroglycan.
Yagi H; Nakagawa N; Saito T; Kiyonari H; Abe T; Toda T; Wu SW; Khoo KH; Oka S; Kato K
Sci Rep; 2013 Nov; 3():3288. PubMed ID: 24256719
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase.
Bao X; Kobayashi M; Hatakeyama S; Angata K; Gullberg D; Nakayama J; Fukuda MN; Fukuda M
Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12109-14. PubMed ID: 19587235
[TBL] [Abstract][Full Text] [Related]
15. SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan function.
Yoshida-Moriguchi T; Willer T; Anderson ME; Venzke D; Whyte T; Muntoni F; Lee H; Nelson SF; Yu L; Campbell KP
Science; 2013 Aug; 341(6148):896-9. PubMed ID: 23929950
[TBL] [Abstract][Full Text] [Related]
16. Investigating the functions of LARGE: lessons from mutant mice.
Hewitt JE
Methods Enzymol; 2010; 479():367-86. PubMed ID: 20816177
[TBL] [Abstract][Full Text] [Related]
17. Identification and Modeling of a GT-A Fold in the α-Dystroglycan Glycosylating Enzyme LARGE1.
Righino B; Bozzi M; Pirolli D; Sciandra F; Bigotti MG; Brancaccio A; De Rosa MC
J Chem Inf Model; 2020 Jun; 60(6):3145-3156. PubMed ID: 32356985
[TBL] [Abstract][Full Text] [Related]
18. Posttranslational modification of alpha-dystroglycan, the cellular receptor for arenaviruses, by the glycosyltransferase LARGE is critical for virus binding.
Kunz S; Rojek JM; Kanagawa M; Spiropoulou CF; Barresi R; Campbell KP; Oldstone MB
J Virol; 2005 Nov; 79(22):14282-96. PubMed ID: 16254363
[TBL] [Abstract][Full Text] [Related]
19. The inside and out of dystroglycan post-translational modification.
Moore CJ; Winder SJ
Neuromuscul Disord; 2012 Nov; 22(11):959-65. PubMed ID: 22770978
[TBL] [Abstract][Full Text] [Related]
20. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
Kanagawa M; Nishimoto A; Chiyonobu T; Takeda S; Miyagoe-Suzuki Y; Wang F; Fujikake N; Taniguchi M; Lu Z; Tachikawa M; Nagai Y; Tashiro F; Miyazaki J; Tajima Y; Takeda S; Endo T; Kobayashi K; Campbell KP; Toda T
Hum Mol Genet; 2009 Feb; 18(4):621-31. PubMed ID: 19017726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
